News for Hologic, Inc. (HOLX.MX)

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Mizuho has revised its price target for Hologic (HOLX), reducing it from $83 to $75, while maintaining an Outperform rating on the stock. This adjustment comes

Bank of America has adjusted its price target for Hologic (HOLX), scaling it down to $70 from a previous $86, while maintaining a Neutral rating on the company'

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Hologic Inc (HOLX) has announced the election of Wayde McMillan to its Board of Directors, effective April 4, 2025. Mr. McMillan, who brings a wealth of experie

Hologic, Inc. (Nasdaq: HOLX) announced today that Wayde McMillan has been elected to the Company's Board of Directors, effective April 4, 2025. Mr. McMillan wa

Summary Hologic Inc (HOLX), a leading medical technology company focused on women's health, has announced that it will release its financial results for the sec

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2025 on Thursday, May 1,

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The Good Investors Company Notes Series (#7): iCAD Company Notes :

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Hologic, Inc. (HOLX) has announced that John Griffin (Trades, Portfolio), the company's General Counsel, will retire in 2025 after a distinguished career. Eff

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Hologic Inc (HOLX), a leading medical technology company focused on women's health, announced that it will present at the Raymond James & Associates' 46th Annua

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Aptima® SARS-CoV-

Significant Reduction in Hologic Holdings On December 31, 2024, T. Rowe Price Investment Management, Inc. (Trades, Portfolio) executed a notable reduction in it

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.